Suppliers and packagers for elinest

elinest

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Novast Labs Ltd	ELINEST	ethinyl estradiol; norgestrel	TABLET;ORAL-28	091105	ANDA	Northstar Rx LLC	16714-365-01	1 BLISTER PACK in 1 PACKET (16714-365-01) / 1 KIT in 1 BLISTER PACK	2012-01-07
Novast Labs Ltd	ELINEST	ethinyl estradiol; norgestrel	TABLET;ORAL-28	091105	ANDA	Northstar Rx LLC	16714-365-02	1 BLISTER PACK in 1 CARTON (16714-365-02) / 1 KIT in 1 BLISTER PACK	2012-01-07
Novast Labs Ltd	ELINEST	ethinyl estradiol; norgestrel	TABLET;ORAL-28	091105	ANDA	Northstar Rx LLC	16714-365-03	3 BLISTER PACK in 1 CARTON (16714-365-03) / 1 KIT in 1 BLISTER PACK	2012-01-07
Novast Labs Ltd	ELINEST	ethinyl estradiol; norgestrel	TABLET;ORAL-28	091105	ANDA	Northstar Rx LLC	16714-365-04	6 BLISTER PACK in 1 CARTON (16714-365-04) / 1 KIT in 1 BLISTER PACK	2012-01-07

Suppliers for the Pharmaceutical Drug: ELINEST

Last updated: August 2, 2025

Introduction

ELINEST is a combined oral contraceptive formulation comprising levonorgestrel and ethinylestradiol. Widely used for pregnancy prevention, cycle regulation, and management of hormonal imbalances, ELINEST has secured its place in reproductive health. The medication is marketed globally under various brand names but generally features a consistent formulation. With broad application, supply chain stability is essential for pharmaceutical companies and healthcare providers. This article examines the key suppliers involved in manufacturing and distributing ELINEST, including active pharmaceutical ingredient (API) providers, finished drug manufacturers, and regional distributors.

---

Manufacturers of ELINEST

ELINEST’s production involves a complex supply chain, beginning with high-purity active pharmaceutical ingredients (APIs), followed by formulation, packaging, and distribution. Major pharmaceutical corporations and generic manufacturers operate across different regions, ensuring supply consistency.

1. Originator Pharmaceutical Companies

The original innovator of ELINEST was Schering AG, now part of Bayer AG. Bayer remains a leading supplier of the brand, controlling manufacturing, formulation, and global distribution.

• Bayer AG: Bayer maintains extensive manufacturing capabilities for APIs and finished products. Its global supply chain includes multiple manufacturing sites specializing in hormonal compounds such as levonorgestrel and ethinylestradiol[1].

2. API Suppliers

The efficacy of ELINEST hinges on high-grade APIs—levonorgestrel and ethinylestradiol. A variety of suppliers provide these APIs globally, often to multiple pharmaceutical firms, both branded and generic.

• Bayer’s In-House API Production: Bayer produces its APIs in proprietary facilities, ensuring quality control and consistent supply.

• Contract Manufacturing Organizations (CMOs): Several CMOs supply APIs to pharmaceutical companies manufacturing ELINEST or its generics. Notably:

  • Hetero Labs (India): Supplies APIs and intermediates for hormonal medications, including levonorgestrel[2].

  • IPCA Laboratories (India): Known for manufacturing ethynylestradiol and levonorgestrel APIs with high purity levels[3].

  • MBL (India): Produces both APIs and formulations of hormonal drugs, including components used in ELINEST.

  • Suzhou Xiangxue Pharmaceutical (China): A regional supplier of ethynylestradiol with GMP certification.

• European and North American API Suppliers: Companies such as Sterling Pharmaceutical and Piramal Enterprises also produce APIs for hormonal contraceptives, focusing on regulatory compliance and high-quality standards.

3. Generic Manufacturers

In addition to Bayer, numerous generic pharmaceutical firms manufacture ELINEST or equivalent formulations, often sourcing APIs from global suppliers.

• Teva Pharmaceutical Industries (Israel): Manufactures hormonal contraceptive pills, sourcing APIs from various regions, including India and China.

• Mylan (now part of Viatris): Operates extensive manufacturing facilities producing combination oral contraceptives, with APIs procured from multiple regions.

• Sandoz (Novartis): Supplies generic contraceptive tablets, with API input from global suppliers to meet quality standards.

4. Regional Distributors and Supply Chain Entities

Distribution channels span wholesaler networks, regional distributors, and pharmacies. These entities ensure the availability of ELINEST across different markets.

• Global Distributors: McKesson, Cardinal Health, and Walgreens Boots Alliance manage sizable inventories and distribution logistics for contraceptive products.

• Regional Pharmacies: Local hospitals, clinics, and community pharmacies serve as vital nodes in ELINEST distribution, reliant on regional supply agreements.

---

Supply Chain Considerations for ELINEST

Regulatory Compliance & Quality Standards

High-quality APIs and finished pharmaceuticals require adherence to Good Manufacturing Practices (GMP). Suppliers such as Hetero, IPCA, and others maintain certifications from agencies like the US FDA, EMA, or local regulatory bodies, which influence their procurement favorability.

Raw Material Procurement & Geopolitical Factors

The supply chain for APIs predominantly depends on India, China, and European suppliers. Geopolitical tensions, trade policies, and regulatory changes can impact the availability and pricing:

• India: Major API hub, providing approximately 50% of world's generic API production, including hormonal compounds[4].

• China: Growing API manufacturing capacity with competitive pricing, but regulatory fluctuations can affect supply stability.

Manufacturing Capacity and Lead Times

Manufacturers invest in expanding capacity to meet global demand, especially amid increasing contraceptive needs. However, supply constraints, raw material shortages, and regulatory delays can cause periodic shortages of ELINEST and its APIs.

---

Emerging Trends & Future Outlook

1. Biotechnological Advancements

Research into bioidentical hormone synthesis may redefine sourcing, with potential shifts toward recombinant methods or biosynthetic pathways, reducing dependency on traditional chemical synthesis.

2. Regional Manufacturing Expansion

Countries like India and China continue to expand API manufacturing capacities, aiming for greater self-sufficiency and supply resilience for hormonal drugs such as ELINEST.

3. Regulatory Harmonization

Efforts by agencies like the International Council for Harmonisation (ICH) aim to standardize manufacturing and quality standards, facilitating smoother international supply chains.

---

Key Takeaways

• Bayer remains the primary supplier of ELINEST, controlling both API production and finished drug manufacturing.

• A vast network of Indian, Chinese, and European API suppliers—namely Hetero Labs, IPCA Laboratories, and others—serve as critical sources for APIs used in ELINEST.

• Generic manufacturers like Teva, Mylan, and Sandoz rely on these API suppliers to produce cost-effective alternatives, ensuring broad availability.

• Supply chain resilience depends on geopolitical stability, regulatory compliance, and capacity expansion; ongoing geopolitical and trade tensions pose risks.

• The future trend favors regional API manufacturing growth, regulatory harmonization, and potential biotechnological shifts in hormone synthesis.

---

FAQs

1. Who are the leading API suppliers for levonorgestrel used in ELINEST?
Major suppliers include Indian firms such as Hetero Labs and IPCA Laboratories, with additional contributions from Chinese and European manufacturers. Bayer produces its own APIs, ensuring quality control for its branded products.

2. Can generic versions of ELINEST be produced without API sourcing from India or China?
While some generic manufacturers may develop APIs locally or through alternative suppliers, the majority rely on Indian and Chinese API producers due to cost, capacity, and established quality standards.

3. How does supply chain disruption impact ELINEST availability?
Disruptions in API supply—due to geopolitical tensions, regulatory delays, or raw material shortages—can result in manufacturing delays or shortages of ELINEST. Manufacturers mitigate risks through inventory management and diversified sourcing.

4. What role do regulatory agencies play in ELINEST supply stability?
Regulatory agencies enforce GMP standards, approve manufacturing sites, and monitor quality, impacting supplier credibility and supply continuity. Certified suppliers are prioritized to ensure drug safety and efficacy.

5. Are there regional differences in the supply of ELINEST?
Yes, supply dynamics vary regionally, influenced by local manufacturing capabilities, import regulations, and market demand. Developed markets often have multiple approved suppliers ensuring supply stability, whereas emerging markets may depend heavily on imported APIs.

---

References

[1] Bayer AG. "Bayer's Contraceptive Portfolio," Bayer Official Website.
[2] Hetero Labs. "API Manufacturing Capabilities," Company Reports.
[3] IPCA Laboratories. "Hormonal APIs for Contraceptives," Annual Report.
[4] World Health Organization. "Global API Production," Pharmaceutical Section, 2022.